Search - tctmd.com

Displaying 181 - 200 of 280

Sort: Relevancy | Date

News Industry News

Boston Scientific Enrolls First Patients In U.S. Trial Of The Lotus™ Valve System

September 23, 2014

News Conference News TCT 2014

Views Differ on Future of Percutaneous Mitral Valve Therapies

September 16, 2014

News Industry News

REPRISE II Data Demonstrate Sustained Safety And Performance Outcomes At One Year For The Boston Scientific Lotus™ Valve System

September 15, 2014

News Conference News TCT 2014

New Devices May Help Overcome the Issue of Paravalvular Regurgitation After TAVR

September 15, 2014

News Conference News TCT 2014

TCT Course Director Outlines Current TAVR Controversies

September 14, 2014

News Conference News TCT 2014

Moderate-to-Severe AR After TAVR May Yield Greater Mortality Risk

September 13, 2014

News Conference News ESC 2014

Mitral Regurgitation Associated with Decreased Survival in TAVR Patients

Yael L. Maxwell

September 03, 2014

News Daily News

评估主动脉瓣膜钙化可帮助预测TAVR后血管周围泄漏

Yael L. Maxwell

September 02, 2014

News Daily News

Valorar la Calcificación de la Válvula Aórtica Podría Ayudar a Predecir la Fuga Paravalvular post-TAVR

Yael L. Maxwell

September 02, 2014

News Daily News

Assessing Aortic Valve Calcification May Help Predict Paravalvular Leak After TAVR

Yael L. Maxwell

September 02, 2014

News Daily News

第一代TAVR器械之间的主动脉反流风险和结果不同

Caitlin E. Cox

August 07, 2014

News Daily News

Las Consecuencias del Riesgo de Regurgitación Aórtica Varían entre los Dispositivos TAVR de 1ª Generación

Caitlin E. Cox

August 07, 2014

News Daily News

Aortic Regurgitation Risk, Consequences Vary Between First-Generation TAVR Devices

Caitlin E. Cox

August 07, 2014

News Daily News

Local Anesthesia ‘Preferable’ Over General for Transfemoral TAVR

Yael L. Maxwell

July 24, 2014

News Industry News

Boston Scientific Receives CE Mark For The New 25 mm Lotus™ Valve System

July 14, 2014

News Daily News

VIVID Registry: Benefit of Valve-in-Valve TAVR Depends on Size, Status of Failed Surgical Bioprosthesis

July 10, 2014

News Daily News

Some Long-term Drop-Off in Favorable Outcomes Seen in Early CoreValve Series

July 03, 2014

News Daily News

Transesophageal Echo Leads to Wrong CoreValve Sizing in Nearly Half of Patients

L.A. McKeown

June 24, 2014

News Daily News

La Eco Transesofágica Provoca el Dimensionamiento Erróneo de CoreValve en Casi la Mitad de los Pacientes

L.A. McKeown

June 24, 2014

News Industry News

Boston Scientific Initiates the RESPOND Post Market Registry Evaluating Clinical Outcomes in Patients Implanted With Lotus™ Valve System

June 04, 2014

Advertisement

Boston Scientific Enrolls First Patients In U.S. Trial Of The Lotus™ Valve System

Views Differ on Future of Percutaneous Mitral Valve Therapies

REPRISE II Data Demonstrate Sustained Safety And Performance Outcomes At One Year For The Boston Scientific Lotus™ Valve System

New Devices May Help Overcome the Issue of Paravalvular Regurgitation After TAVR

TCT Course Director Outlines Current TAVR Controversies

Moderate-to-Severe AR After TAVR May Yield Greater Mortality Risk

Mitral Regurgitation Associated with Decreased Survival in TAVR Patients

评估主动脉瓣膜钙化可帮助预测TAVR后血管周围泄漏

Valorar la Calcificación de la Válvula Aórtica Podría Ayudar a Predecir la Fuga Paravalvular post-TAVR

Assessing Aortic Valve Calcification May Help Predict Paravalvular Leak After TAVR

第一代TAVR器械之间的主动脉反流风险和结果不同

Las Consecuencias del Riesgo de Regurgitación Aórtica Varían entre los Dispositivos TAVR de 1ª Generación

Aortic Regurgitation Risk, Consequences Vary Between First-Generation TAVR Devices

Local Anesthesia ‘Preferable’ Over General for Transfemoral TAVR

Boston Scientific Receives CE Mark For The New 25 mm Lotus™ Valve System

VIVID Registry: Benefit of Valve-in-Valve TAVR Depends on Size, Status of Failed Surgical Bioprosthesis

Some Long-term Drop-Off in Favorable Outcomes Seen in Early CoreValve Series

Transesophageal Echo Leads to Wrong CoreValve Sizing in Nearly Half of Patients

La Eco Transesofágica Provoca el Dimensionamiento Erróneo de CoreValve en Casi la Mitad de los Pacientes

Boston Scientific Initiates the RESPOND Post Market Registry Evaluating Clinical Outcomes in Patients Implanted With Lotus™ Valve System

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content